Global Vascular Grafts and Peripheral Stents Market, By Product Type (Vascular Graft and Peripheral Stent), Vascular Graft Raw Material Source (Synthetic, Biosynthetic and Biological), Vascular Graft Indication (Endovascular Aneurysm Repair, Peripheral Vascular Repair and Haemodialysis Access), Peripheral Stent Artery Type (Carotid Artery, Fem-Pop Artery, Iliac Artery and Infrapop Artery), Vascular Graft Application (Coronary Artery Disease, Vascular Occlusion, Aneurysm, Renal Failure and Others), End Users (Hospitals, Ambulatory Surgical Centres, Cardiac Catheterization Laboratories, Specialty Clinics and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Rising demand for minimally invasive surgical procedures and development and commercialization of technologically advanced medical equipment are the two factors attributable to the growth of vascular grafts and peripheral stents market. Data Bridge Market Research analyses that the vascular grafts and peripheral stents market will project a CAGR of 6.34% for the forecast period of 2021-2028.
Vascular grafts are used in the bypass surgery to redirect the blood flow from one area to another. The vascular grafts act as a substitute for the abnormal artery so that normal blood flow can be resumed. Peripheral stents are medical devices that are inserted inside a blocked artery. This is done to expand the blocked artery and resume the normal flow of the blood. These stents remain in the arteries for the rest of life.
Rising incidences of cardiovascular diseases and geriatric populations are the two factors propelling the growth of vascular grafts and peripheral stents market. Rising diabetic population will in turn induce the demand for vascular grafts and peripheral stents globally. Rising awareness and demand for minimally invasive surgical procedures will further foster market growth rate.
However, high costs involved in the procedure will restrict the scope of growth. Also, unfavourable reimbursement policies in the developing economies will further hammer down the market growth rate.
This vascular grafts and peripheral stents market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info vascular grafts and peripheral stents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Vascular Grafts and Peripheral Stents Market Scope and Market Size
The vascular grafts and peripheral stents market is segmented on the basis of product type, vascular graft raw material source, vascular graft indication, peripheral stent artery type, vascular graft application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the vascular grafts and peripheral stents market is segmented into vascular graft and peripheral stent. Vascular graft is further sub-segmented into endovascular stent graft, peripheral vascular graft, haemodialysis access graft, bypass graft and others. Endovascular stent graft is further bifurcated into AAA (abdominal aortic aneurysm) and TAA (thoracic aortic aneurysm). Peripheral stent segment is further sub-segmented into covered stents, drug eluting stents, bare metal stents, balloon expanding stents and self-expanding stents.
- Based on vascular graft raw material source, the vascular grafts and peripheral stents market is segmented into synthetic, biosynthetic and biological. Synthetic segmented is sub-segmented into ePTFE and PTFE (expanded- polytetrafluoroethylene and polytetrafluoroethylene), polyester, [olyurethane (PU), dacron and others. Biosynthetic segmented is sub-segmented into ovine collagen with polyester and others. Biological segmented is sub-segmented into bovine vein, saphenous vein and umbilical veins, tissue engineered materials and others.
- Based on vascular graft indication, the vascular grafts and peripheral stents market is segmented into endovascular aneurysm repair, peripheral vascular repair and haemodialysis access. Endovascular Aneurysm repair is sub-segmented into abdominal aortic aneurysm repair and thoracic aortic aneurysm repair.
- On the basis of peripheral stent artery type, the vascular grafts and peripheral stents market is segmented into carotid artery, fem-pop artery, iliac artery and infrapop artery.
- On the basis of vascular graft application, the vascular grafts and peripheral stents market is segmented into coronary artery disease, vascular occlusion, aneurysm, renal failure and others.
- On the basis of end users, the vascular grafts and peripheral stents market is segmented into hospitals, ambulatory surgical centres, cardiac catheterization laboratories, specialty clinics and others.
Vascular Grafts and Peripheral Stents Market Country Level Analysis
The vascular grafts and peripheral stents market is analysed and market size insights and trends are provided by country, product type, vascular graft raw material source, vascular graft indication, peripheral stent artery type, vascular graft application and end users as referenced above.
The countries covered in the vacuum-assisted biopsy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been dominating the vascular grafts and peripheral stents market and will continue to witness a substantial growth for the forecast period. Rising cases of diabetes and cardiovascular diseases are propelling the growth of the market in this region. Asia-Pacific on the other hand will witness the highest CAGR for the forecast period. Rising awareness about vascular grafts and peripheral stents, rising demand for minimally invasive surgical procedures and improving healthcare infrastructure especially in the developing countries will induce the market growth in this region.
The country section of the vascular grafts and peripheral stents market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Vascular grafts and peripheral stents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the vascular grafts and peripheral stents market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Vascular Grafts and Peripheral Stents Market Share Analysis
The vascular grafts and peripheral stents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to vascular grafts and peripheral stents market.
The major players covered in the vascular grafts and peripheral stents market report are Medtronic, Abbott., Boston Scientific Corporation, BIOTRONIK SE & Co KG, B. Braun Melsungen AG, Terumo Corporation, STENTYS SA, Cardinal Health., Meril Life Sciences Pvt. Ltd., Vascular Concept., W. L. Gore & Associates, Inc., BD., ENDOLOGIX LLC., Translumina., JOTEC GmbH, Lombard Medical, Xcell Medical Group, Cardinal Health., Cook and Getinge AB among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.